Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Return on Equity (2020 - 2025)

Pulse Biosciences has reported Return on Equity over the past 6 years, most recently at 0.33% for Q3 2025.

  • Quarterly results put Return on Equity at 0.33% for Q3 2025, up 40.0% from a year ago — trailing twelve months through Sep 2025 was 0.33% (up 40.0% YoY), and the annual figure for FY2024 was 0.67%, changed.
  • Return on Equity for Q3 2025 was 0.33% at Pulse Biosciences, down from 0.35% in the prior quarter.
  • Over the last five years, Return on Equity for PLSE hit a ceiling of 7.9% in Q1 2023 and a floor of 29.69% in Q4 2022.
  • Median Return on Equity over the past 5 years was 0.93% (2021), compared with a mean of 2.12%.
  • Biggest five-year swings in Return on Equity: tumbled -2829bps in 2022 and later soared 983bps in 2023.
  • Pulse Biosciences' Return on Equity stood at 1.4% in 2021, then plummeted by -2018bps to 29.69% in 2022, then surged by 98bps to 0.7% in 2023, then surged by 179bps to 0.55% in 2024, then tumbled by -40bps to 0.33% in 2025.
  • The last three reported values for Return on Equity were 0.33% (Q3 2025), 0.35% (Q2 2025), and 0.4% (Q1 2025) per Business Quant data.